Elkolist 1MIU Injection
Marketer
Elkos Healthcare Pvt Ltd
Salt Composition
Colistimethate Sodium (1Million IU)
Overview Elkolist 1MIU Injection
Elkolist 1MIU Injection, an antibacterial agent, combats severe systemic bacterial infections. Primarily administered to critically ill hospitalized individuals, this injection requires professional healthcare oversight; self-administration is strictly prohibited. Dosage and treatment duration are determined by your physician, contingent upon infection severity and type. Consistent adherence to the prescribed regimen is crucial for optimal therapeutic outcomes. Potential adverse reactions, including nausea, dysarthria, lightheadedness, vertigo, pyrexia, dermatological eruptions, and paresthesia, are generally transient and resolve with continued therapy. However, persistent or bothersome side effects warrant immediate medical attention. Prior to commencing treatment, disclose any antibiotic allergies, hepatic or renal impairments to your physician. Similarly, pregnant or lactating women must seek medical counsel before use. Regular blood tests may be conducted to monitor renal function and serum drug levels.
Uses of Elkolist 1MIU Injection
Life-threatening bacterial infections
Major Benefits of Elkolist 1MIU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Elkolist 1MIU Injection:
- Slurred speech
- Upset stomach
- Dizziness
- Gastrointestinal disturbance
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Rash
- Fever
- Generalized itching
- Red spots or bumps
- Increased blood urea nitrogen
- Increased creatinine level in blood
- Decreased creatinine clearance
- Respiratory distress
- Apnea (absence of breathing)
- Renal toxicity
- Decreased urinary volume
How to use Elkolist 1MIU Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Elkolist 1MIU Injection works:
Elkolist 1MIU Injection is a bactericidal antibiotic that disrupts bacterial cell membranes, leading to bacterial death.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Elkolist 1MIU Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Using Elkolist 1MIU Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Elkolist 1 MIU Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible danger to the infant.
DrivingUNSAFE
Administration of Elkolist 1MIU Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, administering Elkolist 1MIU Injection requires careful consideration. Dosage modifications for Elkolist 1MIU Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Elkolist 1MIU Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Elkolist 1MIU Injection :
NA
Facts to Know About Elkolist 1MIU Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide chains |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently